Board of Directors
David Simmons joined PPD in 2012 as chairman and chief executive officer. In this role, he leads the company’s global workforce of more than 28,000 employees, in the design and execution of drug development programs on behalf of pharmaceutical industry customers.
Under his leadership, PPD’s total enterprise value has more than tripled, the number of employees has more than doubled and the company has received numerous accolades. Simmons was named the recipient of the Louis V. Gerstner, Jr., Excellence Award by The Carlyle Group in 2017 for exemplifying excellence in leading a Carlyle portfolio company.
Simmons came to PPD following 15 years with Pfizer Inc. In his most recent position with Pfizer, he was president of the emerging markets and established products business units.
Simmons serves on the board of directors for Albany Molecular Research, Inc. and Edelman Financial Engines. He also is active in philanthropic endeavors, which includes serving as a trustee of the Linsly School in Wheeling, West Virginia, and a director for First Tee of Greater Wilmington.
Simmons earned a bachelor’s degree in applied mathematics and industrial management from Carnegie Mellon University.